Cardinal Capital Management Boosted Novartis Adr (NVS) Holding By $374,680; CVR Refining LP (CVRR) Sentiment Is 1.1

March 19, 2018 - By Michael Collier

CVR Refining, LP operates as an independent petroleum refiner and marketer of transportation fuels in the United States. The company has market cap of $1.88 billion. It owns and operates a complex full coking medium-sour crude oil refinery in Coffeyville, Kansas. It has a 21.1 P/E ratio. The firm also controls and operates logistics assets, including approximately 340 miles of owned and leased pipelines; approximately 150 owned crude oil transports; a network of crude oil gathering tank farms; and approximately 6.4 million barrels of owned and leased crude oil storage capacity, as well as approximately 4.5 million barrels of combined refined products and feedstocks storage capacity.

Cardinal Capital Management increased Novartis Adr (NVS) stake by 11.5% reported in 2017Q3 SEC filing. Cardinal Capital Management acquired 4,408 shares as Novartis Adr (NVS)’s stock rose 4.17%. The Cardinal Capital Management holds 42,727 shares with $3.67M value, up from 38,319 last quarter. Novartis Adr now has $191.12 billion valuation. The stock decreased 0.48% or $0.39 during the last trading session, reaching $81.67. About 268,917 shares traded. Novartis AG (NYSE:NVS) has risen 7.67% since March 19, 2017 and is uptrending. It has underperformed by 9.03% the S&P500.

Among 16 analysts covering Novartis Ag (NYSE:NVS), 5 have Buy rating, 4 Sell and 7 Hold. Therefore 31% are positive. Novartis Ag had 36 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Novartis AG (NYSE:NVS) earned “Buy” rating by Societe Generale on Wednesday, March 8. The stock has “Hold” rating by Barclays Capital on Friday, June 23. Cowen & Co maintained it with “Hold” rating and $90.0 target in Friday, October 13 report. Cowen & Co maintained the shares of NVS in report on Tuesday, July 18 with “Hold” rating. The firm earned “Market Perform” rating on Wednesday, April 5 by Cowen & Co. Morgan Stanley downgraded the shares of NVS in report on Tuesday, April 12 to “Underperform” rating. The rating was maintained by JP Morgan on Wednesday, April 19 with “Neutral”. The stock of Novartis AG (NYSE:NVS) has “Neutral” rating given on Tuesday, January 3 by JP Morgan. The firm has “Neutral” rating by UBS given on Friday, April 1. The rating was maintained by Chardan Capital Markets with “Buy” on Monday, October 10.

Hite Hedge Asset Management Llc holds 3.25% of its portfolio in CVR Refining, LP for 1.28 million shares. Valueworks Llc owns 150,000 shares or 1.05% of their US portfolio. Moreover, U S Global Investors Inc has 0.39% invested in the company for 108,800 shares. The New York-based Yorkville Capital Management Llc has invested 0.3% in the stock. Icahn Carl C, a New York-based fund reported 5.75 million shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Market News